Longeveron Inc - Ordinary Shares - Class A

NASDAQ:LGVN   2:06:53 PM EDT
4.03
0.00 (0.00%)
Products

U.S. FDA Grants Fast Track Designation For Longeveron’s Lomecel-B

Published: 08/31/2022 12:41 GMT
Longeveron Inc - Ordinary Shares - Class A (LGVN) - U.S. Food and Drug Administration (fda) Grants Fast Track Designation for Longeveron’s Lomecel-b™ Product for Treatment of Hypoplastic Left Heart Syndrome (hlhs) in Infants.